en
Scientific article
Open access
English

Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030

Published inSwiss Medical Weekly, vol. 147, w14543
Publication date2017
Abstract

In Switzerland, the prevalence of hepatitis C virus (HCV) among people who inject drugs (PWID) has been decreasing owing to active harm reduction efforts and an aging population. Recent advances in HCV therapeutics may provide an opportunity to direct treatment to high-risk populations, with a goal of reducing HCV prevalence and preventing new infections. In order to guide these efforts, the current project was undertaken with the following aims: (1) to develop a simple model to estimate the number of new HCV infections using available data on PWID; (2) to examine the impact of intervention strategies (prevention and treatment) on new and total HCV infections among PWID.

Citation (ISO format)
BRUGGMANN, Philip et al. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. In: Swiss Medical Weekly, 2017, vol. 147, p. w14543. doi: 10.4414/smw.2017.14543
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1424-7860
860views
218downloads

Technical informations

Creation06/11/2018 4:21:00 PM
First validation06/11/2018 4:21:00 PM
Update time03/15/2023 8:26:40 AM
Status update03/15/2023 8:26:39 AM
Last indexation02/12/2024 12:52:58 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack